Oncology Nursing News®

Peer Exchange

Select Topic:
Browse by Series:
The Advent of Oral Oncolytics and Patient Access
The Advent of Oral Oncolytics and Patient Access
Unmet Needs in CINV
Unmet Needs in CINV
Use of Dexamethasone in CINV
Use of Dexamethasone in CINV
Use of Olanzapine in CINV
Use of Olanzapine in CINV
5-HT3/NK1 Receptor Antagonist Combinations for CINV
5-HT3/NK1 Receptor Antagonist Combinations for CINV
Role of NK1 Receptor Antagonists in Treating CINV
Role of NK1 Receptor Antagonists in Treating CINV
Role of 5-HT3 Receptor Antagonists in Treating CINV
Role of 5-HT3 Receptor Antagonists in Treating CINV
Treating CINV Due to Immunotherapy and Targeted Therapy
Treating CINV Due to Immunotherapy and Targeted Therapy
Patient Education Materials for CINV
Patient Education Materials for CINV
<< Prev Page
Next Page >>
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.